Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes

Human CD56brightNK Cells: An Update

(2016) Tatiana Michel et al.   JOURNAL OF IMMUNOLOGY

Human NK Cell Diversity in Viral Infection: Ramifications of Ramification

(2016) Dara M. Strauss-Albee et al.   Frontiers in Immunology

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein–Barr Virus

(2016) Olivia Hatton et al.   Frontiers in Immunology

NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation

(2015) Eva María García-Cuesta et al.   Frontiers in Immunology

Role for early-differentiated natural killer cells in infectious mononucleosis

(2014) T. Azzi et al.   BLOOD

Shaping of NK cell subsets by aging

(2014) Rafael Solana et al.   CURRENT OPINION IN IMMUNOLOGY

Effect of age and CMV on NK cell subpopulations

(2014) Carmen Campos et al.   EXPERIMENTAL GERONTOLOGY

Distinct Natural Killer Cells in HIV-Exposed Seronegative Subjects With Effector Cytotoxic CD56dim and CD56bright Cells and Memory-Like CD57+NKG2C+CD56dim Cells

(2014) Josenilson F. Lima et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation

(2014) N. Dulphy et al.   JOURNAL OF IMMUNOLOGY

The mechanism of action of BCG therapy for bladder cancer—a current perspective

(2014) Gil Redelman-Sidi et al.   Nature Reviews Urology

Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition

(2013) Eric O. Long et al.   Annual Review of Immunology

Bacillus Calmette-Guérin immunotherapy for genitourinary cancer

(2013) Nilay M. Gandhi et al.   BJU INTERNATIONAL

NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)

(2013) R. Romee et al.   BLOOD

Mature Cytotoxic CD56bright/CD16+ Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma

(2013) M. Messaoudene et al.   CANCER RESEARCH

Natural killer cell biology: An update and future directions

(2013) Kerry S. Campbell et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets

(2013) E. Mamessier et al.   JOURNAL OF IMMUNOLOGY

Location and cellular stages of natural killer cell development

(2013) Jianhua Yu et al.   TRENDS IN IMMUNOLOGY

Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review

(2011) Tahlita C.M. Zuiverloon et al.   EUROPEAN UROLOGY

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

(2009) C. Fauriat et al.   BLOOD

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets

(2009) J. Yu et al.   BLOOD

A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth

(2009) Tomoe Higuchi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Molecular Analyte Profiling of the Early Events and Tissue Conditioning Following Intravesical Bacillus Calmette-Guerin Therapy in Patients With Superficial Bladder Cancer

(2009) Aurélie Bisiaux et al.   JOURNAL OF UROLOGY